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Introduction
Chronic viral infections such as HIV, HCV, and HBV are a major 
burden on human health due to both their high rates of morbidity 
and mortality as well as to the lack of effective therapies. While vi-
ral evasion of the immune response can directly contribute to viral 
persistence, recent findings indicate that impaired viral clearance 
is also facilitated by host-regulated immunosuppression. In par-
ticular, both the CD4+ and CD8+ T cell response to chronic viral 
infection is impaired, with some antiviral T cells failing to survive 
(termed “deletion”) and others persisting in a dysfunctional or 
“exhausted” state characterized by diminished effector function 
(1, 2). In particular, exhausted antiviral T cells lose effector cyto-
kine production capacity to varying degrees depending on exhaus-
tion severity, with cells first losing IL-2 production, followed by 
TNF-α and finally IFN-γ. This process is regulated by T cell gene 
expression changes, including inhibitory receptor induction (3, 4), 
and by soluble factors such as IL-10 and TGF-β (5–7). Importantly, 
blockade of these pathways restores T cell numbers and function 
and triggers a reduction in viral loads (3–7), validating immuno-
modulation as a viable therapy for chronic viral infections.
Despite our increasing knowledge of the molecules involved 
in immunoregulation during chronic viral infection, the signals 
that induce inhibitory molecule expression remain unclear. In or-
der to address this question, we focused on regulation of the cyto-
kine IL-10. IL-10 expression is elevated during mouse infection 
with the chronic clone 13 (Cl.13) lymphocytic choriomeningitis 
virus (LCMV) strain relative to infection with acute LCMV Arm-
strong (Arm) (5, 6). In addition, Cl.13-infected Il10–/– mice display 
enhanced T cell function and augmented viral clearance (5, 6). El-
evated IL-10 expression has also been implicated in immunoreg-
ulation during human HIV and HCV infection (8–11), suggesting 
that it is part of an evolutionarily conserved response to chronic 
viral infection with clinical relevance. To determine the factors 
controlling IL-10 induction during chronic viral infection, it is first 
necessary to determine the physiologically relevant cellular IL-10 
sources. Hematopoietic cells are the primary source of IL-10 (12), 
however, while a large array of cell types, including DCs, NK cells, 
monocytes, B cells, and T cells, produce IL-10 during chronic viral 
infection (1, 5, 6, 8–15), the physiological relevance of these differ-
ent IL-10 sources in vivo is controversial.
To better understand IL-10 regulation during chronic viral 
infection, we wished to first definitively trace the cellular sources 
of IL-10 during mouse LCMV-Cl.13 infection, then identify those 
cellular IL-10 sources that have an impact on viral clearance, and 
finally identify the factors responsible for IL-10 induction within 
these cells. We reasoned that cell types that produce more IL-10 
in chronic versus acute LCMV infection (“overproducers”) would 
represent the most physiologically relevant sources of IL-10. Us-
ing an IL-10 reporter mouse, we identified virus-specific T cells, 
particularly CD4+ T cells, as one of the few cell types that over-
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the Thy1.1 cDNA (containing a stop codon) inserted upstream of 
the Il10 locus. As a result, Thy1.1 expression is controlled by the 
Il10 gene regulatory elements in these mice, such that cells tran-
scribing Il10 express Thy1.1 on their cell surface.
To validate that 10BiT mice respond normally to LCMV-Cl.13 
infection, we first determined whether the T cell response kinetics 
and viral persistence were similar in C57BL/6 (B6) versus 10BiT 
mice. T cell responses in 10BiT mice were comparable to those 
seen in B6 mice, although viral clearance was slightly delayed in 
the reporter mice (Supplemental Figure 1; supplemental material 
available online with this article; doi:10.1172/JCI66108DS1). To 
begin profiling IL-10 production kinetics, 10BiT mice were either 
infected with a high LCMV-Cl.13 dose (2 × 106 PFU) to establish 
chronic infection or 2 × 105 PFU LCMV-Arm to establish acute 
infection. To further confirm that any differences we observed in 
IL-10 production were due to viral persistence rather than to viral 
tropism differences between the LCMV-Arm and Cl.13 strains, we 
also infected mice with a low LCMV-Cl.13 dose (1 × 102 PFU) to 
generate an acute Cl.13 infection. When the IL-10 reporter (Thy1.1) 
expression kinetics were examined within all splenocytes, we ob-
served a similar percentage of IL-10–expressing cells between 
acute and chronic LCMV infection at early time points (day 5 post 
infection [p.i.]), but we found a higher frequency of IL-10–express-
produced IL-10 over the course of chronic LCMV infection and 
demonstrated that T cell–derived IL-10 was physiologically rel-
evant. IL-10 expression was restricted to Th1 cells within the vi-
rus-specific CD4+ T cell population and was BLIMP-1 dependent. 
Strikingly, IL-10 production appeared enriched within Th1 cells 
with diminished inflammatory function. BLIMP-1 expression 
was higher in Th1 cells in chronic versus acute infection, and an-
tigen engagement during acute infection was sufficient to cause 
BLIMP-1 upregulation and the rapid formation of IL-10–producing 
Th1 cells. Finally, the signaling requirements for antigen-induced 
IL-10 expression compared with antigen-induced inflammatory 
cytokine production appear distinct. Collectively, these data iden-
tify Th1 cells as a physiologically relevant IL-10 source and impli-
cate antigen-induced BLIMP-1 expression within Th1 cells as a 
key factor that leads to sustained IL-10 production and dampened 
T cell responses during chronic viral infection.
Results
Multiple cell types produce IL-10 during chronic LCMV-Cl.13 infec-
tion. To identify cell types that overproduce IL-10 during chronic 
versus acute LCMV infection, 10BiT reporter mice were infected 
with LCMV (16). 10BiT reporter mice possess a bacterial artificial 
chromosome transgene containing the Il10 gene locus, but with 
Figure 1. IL-10 reporter expression ki-
netics during chronic versus acute LCMV 
infection. (A and B) 10BiT reporter mice 
were infected with either 2 × 105 PFU  
LCMV-Arm or 1 × 102 PFU LCMV-Cl.13 
(Acute Cl.13) to establish an acute infec-
tion or 2 × 106 PFU LCMV-Cl.13 (Chronic 
Cl.13) to establish a chronic infection. 
The Thy1.1 IL-10 reporter–positive cell 
percentage was measured over time in 
either spleen (A and B), blood (B), or BM 
(B). Gates used to determine the Thy1.1+ 
percentage were set using transgene-neg-
ative control animals. (A) Representative 
Thy1.1 staining in splenocytes and (B) 
data compiled from 2 to 5 independent 
experiments (n = 4–16 mice/time point). 
(C) 10BiT reporter mice were infected with 
2 × 106 PFU LCMV-Cl.13, and on day 8 p.i., 
FACS-purified Thy1.1+ and Thy1.1– sple-
nocytes were left unstimulated or were 
stimulated for 6 hours with PMA and 
ionomycin. Supernatant IL-10 concentra-
tions were then measured by ELISA. Bar 
graphs show the pooled data of the IL-10 
amount produced per 1 × 106 cells from 3 
independent experiments.
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the greatest basal and inducible capacity to produce IL-10 during 
chronic LCMV-Cl.13 infection.
We next examined IL-10 expression levels within different 
cell populations over the course of chronic and acute LCMV infec-
tion. We were unable to consistently detect appreciable Thy1.1 ex-
pression within neutrophils, but all other cell types showed some 
degree of IL-10 upregulation during LCMV infection (Figure 2, A 
and B). Notably, B cells, FOXP3+ Tregs, NK cells, plasmacytoid 
DCs (pDCs), CD8+ and CD11b+ conventional DCs (cDCs), and ac-
tivated (CD44hi) CD8+ and CD4+ T cells showed increased IL-10 
production over the course of chronic versus acute LCMV infec-
tion (Figure 2, A and B). In contrast, while monocytes displayed 
increased IL-10 production during LCMV infection, we observed 
no difference in the IL-10 production kinetics between chronic 
and acute LCMV infection (Figure 2A). Collectively, these data 
suggest that many cell types contribute to the IL-10 pool during 
chronic LCMV-Cl.13 infection.
Virus-specific T cells overproduce IL-10 over the course of chronic 
LCMV-Cl.13 infection. We decided to further investigate the IL-10 
overproduction observed within the activated CD4+ and CD8+ T 
cell compartments, as it implied that virus-specific T cells might 
be self-regulating during LCMV-Cl.13 infection. To directly exam-
ine whether virus-specific T cells produce IL-10, we stained 10BiT 
splenocytes with either the LCMV GP33–41–specific MHC class I 
ing cells in chronic LCMV infection from day 8 p.i. onward (Figure 1, 
A and B). Specifically, 25%–30% of splenocytes produced IL-10 
during peak viremia, with the IL-10+ cell proportion declining in 
parallel with the drop in viral titers from day 20 of infection on-
ward. These kinetics are similar to published data on IL-10 protein 
and transcript expression (5, 6, 17, 18), validating the accuracy of 
reporter expression. IL-10 expression was additionally tracked in 
blood and BM cells, and similar kinetics were observed (Figure 1B), 
although the IL-10+ cell proportions varied between these tissues.
To further validate the accuracy of Thy1.1 reporter expression, 
IL-10 production was examined on day 8 of chronic LCMV-Cl.13 
infection in 10BiT mice. Since we were unable to reliably detect 
IL-10 protein by intracellular staining above the background seen 
in infection-matched Il10–/– control animals (data not shown), we 
used an ELISA approach to validate the reporter. On day 8 p.i., 
10BiT splenocytes were either left unsorted or were sorted into 
IL-10 reporter–positive (Thy1.1-positive) and –negative subsets. 
To measure IL-10 production, cells were cultured for a short time 
(6 hours) with or without stimulation with the mitogens PMA and 
ionomycin, and IL-10 levels were measured in the cell superna-
tants by ELISA. This assay definitively demonstrated that all basal 
and inducible IL-10 production observed within the total sple-
nocyte population was solely contained within the Thy1.1+ cells 
(Figure 1C). Thus, the Thy1.1 reporter accurately marks cells with 
Figure 2. IL-10 production by different cell types across the course of chronic and acute LCMV infection. (A and B) 10BiT reporter mice were infected with 
either LCMV-Arm, acute Cl.13, or chronic Cl.13, as in Figure 1. The Thy1.1 IL-10 reporter–positive cell percentage was measured in the spleen at various times 
p.i. IL-10 phenotyping in DCs was performed in a different set of experiments (B), in which the spleen was digested with collagenase and DNase followed 
by magnetic cell–sorting (MACS) enrichment of CD11c+ cells prior to measurement of Thy1.1 expression. Pooled data from 2 to 5 independent experiments 
are shown (n = 4–16 mice/time point).
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To confirm that the elevated reporter expression within 
virus-specific CD4+ and CD8+ T cells leads to higher IL-10 
protein levels, we assessed IL-10 production by virus- 
specific T cells by ELISA. Naive, congenically marked 
CD8+GP33+ TCR transgenic (P14) and CD4+GP66+ TCR 
transgenic (Smarta, or STg) cells were transferred into B6 
mice that were then infected with either LCMV-Arm or 
Cl.13. On day 8 p.i., the splenic STg and P14 cells were iso-
lated and their IL-10 production assessed following α-CD3 
stimulation. Naive P14 and STg cells were unable to pro-
duce IL-10, but cells isolated from either LCMV-Arm– or 
LCMV-Cl.13–infected mice produced IL-10 upon TCR liga-
tion (Figure 3C). Importantly, both P14 and STg cells from 
LCMV-Cl.13–infected mice produced more IL-10 than did 
their LCMV-Arm–derived counterparts (2- and 3-fold more 
IL-10, respectively) (Figure 3C). Furthermore, consistent 
with the higher Thy1.1 reporter MFI within CD4+GP66+ 
cells, STg cells generated approximately 10-fold more IL-10 than 
did P14 cells during LCMV-Cl.13 infection. Thus, virus-specific 
T cells produce more IL-10 protein in chronic versus acute infec-
tion, with CD4+ T cells producing considerably more IL-10 than do 
CD8+ T cells on a per-cell basis.
Virus-specific T cell–derived IL-10 is required to fully suppress 
T cell responses during LCMV-Cl.13 infection. To assess the in vivo 
relevance of T cell–derived IL-10 in viral persistence and T cell 
dysfunction, a series of BM chimeras were generated. As a positive 
control for the IL-10 KO phenotype, 1 group of mice was lethally 
irradiated and reconstituted with Il10–/– BM to generate a mouse 
in which all hematopoietic cells were IL-10 deficient (Total KO 
group). Next, we created mixed BM chimeras with 75% Tcra–/– BM 
mixed with 25% Il10–/– BM (T cell KO group) to generate mice with 
an IL-10 deficiency selectively within the T cell compartment. In 
these T cell KO chimeras, all T cells will be IL-10 deficient, while 
the majority (~75%) of the non–T cells will be IL-10 sufficient. As a 
control for WT mice, we also generated mixed BM chimeras con-
tetramer to identify CD8+GP33+ T cells or the LCMV GP66–77–spe-
cific MHC class II tetramer to identify CD4+GP66+ T cells and ex-
amined Thy1.1 expression. IL-10 production was evident within 
the virus-specific T cell compartment over the entire course of 
chronic LCMV-Cl.13 infection (Figure 3A and Supplemental Fig-
ure 2). While CD8+GP33+ and CD4+GP66+ cells expressed compa-
rable levels of IL-10 between chronic and acute LCMV on day 5 p.i., 
elevated IL-10 production was evident during chronic LCMV from 
day 8 p.i. onward. The higher level of IL-10 reporter expression 
on day 8 p.i. was not restricted to CD8+GP33+ cells, as CD8+ cells 
specific for LCMV NP396–404 and GP276–284 also displayed elevated 
reporter expression in chronic versus acute LCMV infection at this 
time point (Supplemental Figure 3). Interestingly, while a larger 
CD8+GP33+ cell percentage expressed Thy1.1 than did CD4+GP66+ 
cells, the Thy1.1+ CD4+GP66+ cells had a 3-fold higher Thy1.1 
MFI than did Thy1.1+ CD8+GP33+ cells, suggesting that the virus- 
specific CD4+ T cells produced more IL-10 on a per-cell basis than 
did CD8+ T cells (Figure 3B).
Figure 3. Virus-specific T cells overproduce IL-10 over the course 
of chronic LCMV infection. (A) 10BiT mice were infected with either 
LCMV-Arm, acute Cl.13, or chronic Cl.13, as in Figure 1. Thy1.1 expres-
sion was examined in tetramer+ splenic CD8+GP33+ or CD4+GP66+  
T cells. Data were pooled from 3 to 6 independent experiments  
(n = 7–16 mice/time point). (B) Thy1.1 levels were compared be-
tween CD8+GP33+ (GP33) and CD4+GP66+ (GP66) cells. Left panels 
show Thy1.1 staining in Db-GP33 tetramer–stained CD8+ cells (top 
panels, gated on CD8+ cells) or I-Ab-GP66 tetramer–stained CD4+ 
cells (bottom panels, gated on CD4+ cells) from 10Bit transgene–
positive (right) or –negative (left) mice. Representative histogram 
(far right, top) shows CD4+GP66+ (red) and CD8+GP33+ (blue) cell 
Thy1.1 staining, with background staining from 10BiT– cells shown 
in gray. Graph (far right, bottom) depicts Thy1.1 MFI of Thy1.1+ cells. 
Data from 3 independent experiments are shown. ***P < 0.001. 
(C) Congenically marked Ly5.1+ P14 and STg cells were transferred 
into B6 mice that were subsequently infected with either 2 × 105 
PFU LCMV-Arm or 2 × 106 PFU LCMV-Cl.13. On day 8 p.i., splenic P14 
and STg cells were isolated by FACS and, along with FACS-purified 
naive P14 and STg cells, were cultured in the presence or absence of 
plate-bound α-CD3 for 12 hours. Supernatant IL-10 concentrations 
were measured by ELISA. Data show IL-10 production per 1.5 × 105 
cells, with values pooled from 2 independent experiments.
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viral clearance within total KO chimeras was weaker than originally 
published, likely because BM chimeras have lower overall T cell 
numbers than do untreated mice due to incomplete reconstitution 
and altered lymphoid architecture. Nevertheless, a clear boost in 
the antiviral immune response was observed in total KO chimeras 
that could be used as a reference for the other BM chimera groups.
When we examined the magnitude of the CD8+GP33+ and 
CD8+NP396+ T cell responses in T cell KO BM chimeras, the re-
sponses were of a similarly elevated magnitude to those in total 
KO chimeras (Figure 4A, B). IL-10 loss from the CD4 compart-
ment only partially phenocopied the total KO CD8+GP33+ and 
CD8+NP396+ responses, while IL-10 loss from the CD8 com-
partment had no effect on the CD8+ T cell response (Figure 4, 
A and B, and Supplemental Figure 4A). IL-10 ablation from the 
total T cell compartment only partially boosted the CD4+GP66+ 
T cell response to the levels seen in the total KO chimera controls. 
Again, the response was weaker in CD4 T cell KO chimeras and 
unchanged in CD8 T cell KO mice.
Importantly, IL-10 ablation from the total T cell compart-
ment, and to a lesser extent the CD4 T cell compartment, also 
contributed to better viral control (Figure 4C). Consistent with 
the unchanged T cell response in CD8 T cell KO mice, these mice 
taining 75% Tcra–/– BM and 25% Il10+/+ B6 BM (T cell WT group). To 
examine the role of IL-10 production by CD4+ and CD8+ T cells in-
dividually, we also generated chimeras containing 75% Cd4–/– BM 
mixed with 25% Il10–/– BM (CD4 T cell KO group) or 75% Cd8a–/– 
BM mixed with 25% Il10–/– BM (CD8 T cell KO group), along with 
their corresponding WT control groups.
The BM chimeras were infected with LCMV-Cl.13, and on 
day 8 p.i., we examined both the antiviral T cell response and vi-
ral titers. As some sickness and mortality was observed within the 
BM chimeras from ~day 10 of infection onward, we restricted our 
analysis to day 8 p.i. Consistent with previously published data on 
IL-10 KO mice (5, 6), there was a considerable increase in the mag-
nitude of both the CD8+GP33+ and CD4+GP66+ responses in total 
KO chimeras compared with those of the WT control groups (Fig-
ure 4, A and B, and Supplemental Figure 4A). Furthermore, IL-10 
deficiency rescued CD8+ T cells specific for the NP396–404 epitope 
(CD8+NP396+) from deletion, as was previously reported (5). We 
observed a corresponding decrease in organ viral titers (Figure 4C 
and Supplemental Figure 4B), suggesting that the augmented T cell 
response provides better viral control. We observed no consistent 
decline in serum viral titers within total KO chimeras relative to 
those in WT controls (data not shown), and the magnitude of organ 
Figure 4. T cell–derived IL-10 
suppresses virus-specific T cell 
responses and viral clearance during 
chronic LCMV infection. Irradiated 
BM chimeras were generated with 
either 100% Il10–/– BM (Total KO), 75% 
Tcra–/– plus 25% B6 BM (T cell WT), 
75% Tcra–/– plus 25% Il10–/– BM (T cell 
KO), 75% Cd4–/– plus 25% B6 BM (CD4 
T cell WT), or 75% Cd4–/– plus 25% 
Il10–/– BM (CD4 T cell KO). BM chime-
ras were infected with 2 × 106 PFU 
LCMV-Cl.13, and the T cell response 
and viral load were measured on day 
8 p.i. (A and B) Bar graphs show the 
percentage of either tetramer+ cells 
specific for the indicated epitopes (A) 
or IFN-γ–producing (B) CD8+ T cells in 
response to either GP33 (CD8+GP33+) 
or NP396 (CD8+NP396+) peptide stim-
ulation (left 2 panels) or the percent-
age of IFN-γ–producing CD4+ T cells in 
response to GP66 peptide stimulation 
(CD4+GP66+, far right panel). (C) Viral 
titers in the liver or kidney. *P < 0.05; 
**P < 0.01; NS, indicates P > 0.05. 
Data were pooled from 2 independent 
experiments (n = 4–8 mice/group).
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exhibited no change in viral control (Supplemental Figure 4B). 
However, viral titers in the total T cell KO mice (and in the CD4 T 
cell KO mice) were still slightly higher than titers in mice lacking 
IL-10 in all immune cells (Total KO), indicating that IL-10 produced 
by non–T cells also regulates viral control during chronic LCMV 
infection (Figure 4C). Importantly, it is unlikely that Tregs are an 
important IL-10 source, as Treg depletion was unable to pheno-
copy the Il10–/– phenotype (Supplemental Figure 5). Collectively, 
these data indicate that T cell–derived IL-10 is physiologically rel-
evant and contributes to both viral persistence and suppression of 
virus-specific T cells during chronic viral infection. Furthermore, 
while combined IL-10 production by both CD4+ and CD8+ T cells 
has the greatest effect on the immune response, CD4+ T cell– 
derived IL-10 (likely from FOXP3– effector cells) has a bigger im-
pact than CD8+ T cell–derived IL-10.
IL-10 is produced by virus-specific Th1 cells with diminished inflam-
matory function, not by Tfh cells. We next characterized the pheno-
type of the IL-10–producing, virus-specific CD8+ and CD4+ T cells. 
Consistent with previously published findings (13, 19), the IL-10–
producing CD8+ T cells expressed greater amounts of the inhibitory 
receptors PD-1, LAG3, and 2B4 (Figure 5A and Supplemental Fig-
ure 6A). We observed that the IL-10+ CD8+ T cells could degranu-
late (surface CD107a+) and produce IFN-γ, however, the IL-10+ cells 
were enriched in cells with lower TNF-α production, a key signature 
of T cell exhaustion (Figure 5B and Supplemental Figure 6B). As 
almost no IL-2 production was detected within the stimulated CD8+ 
T cells during LCMV-Cl.13 infection, the correlation between IL-10 
and IL-2 could not be assessed. Thus, IL-10 production appears to 
be restricted to exhausted CD8+ effector T cells with less inflamma-
tory function and higher inhibitory receptor expression.
Figure 5. IL-10 production is restricted 
to exhausted CD8+ T cells and Th1 
cells with diminished inflamma-
tory function. (A) Splenic Thy1.1+ 
CD8+GP33+ tetramer+ cell phenotypes 
in LCMV-Cl.13–infected (2 × 106 PFU) 
10BiT mice on day 8 p.i. Data are 
representative of 2 independent ex-
periments (n = 5 mice). (B) Correlation 
between cytokine or CD107a expression 
and Thy1.1 levels within α-CD3–stim-
ulated CD8+ T cells on day 8 p.i. with 
Cl.13. The TNF-α plot was gated on 
CD8+IFN-γ+ cells. Data are represen-
tative of 2 independent experiments 
(n = 5 mice). Numbers represent 
the quadrant frequency. (C) The Tfh 
and Th1 phenotype of splenic Thy1.1+ 
CD4+GP66+ tetramer+ 10BiT cells on day 
8 p.i. with Cl.13. Data are representa-
tive of 3 independent experiments  
(n = 8–10 mice). (D) The Thy1.1+ 10BiT 
cell proportion within the non-Tfh  
(PSGL1hiCXCR5lo) and Tfh (PSGL1lo 
CXCR5hi) cell populations on days 
8 and 20 p.i. with Cl.13. Data were 
pooled from 2 to 4 independent 
experiments (n = 11–13/time point). 
***P < 0.001. (E) Plots showing IFN-γ 
and CD107a production within α-CD3–
stimulated CD4+ T cells or TNF-α and 
IL-2 production within CD4+IFN-γ+ 
cells on day 8 p.i. with Cl.13. Data are 
representative of 2 to 3 independent 
experiments (n = 5–8 mice total). 
Numbers represent the quadrant fre-
quency. (F) Congenically marked Ly5.1+ 
STg 10BiT cells were transferred into 
B6 mice subsequently infected with 
2 × 106 PFU LCMV-Cl.13. Donor Thy1.1+ 
and Thy1.1– STg 10BiT cells were sorted 
on day 8 p.i., and Il10 and Il21 mRNA 
levels were assessed by quantitative 
RT-PCR. *P < 0.05; NS, indicates  
P > 0.05. Data were pooled from 3 
independent experiments.
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To examine the phenotype of the IL-10–expressing virus-spe-
cific CD4+ T cells, we first characterized the Th effector subsets that 
form on day 8 of LCMV-Cl.13 infection. Similar to LCMV-Arm infec-
tion (20) and consistent with other LCMV-Cl.13 phenotyping studies 
(1), we found little evidence of Th17, Th2, or induced Treg (iTreg) cell 
formation within virus-specific CD4+GP66+ T cells on day 8 p.i. (data 
not shown). Instead, as during LCMV-Arm infection (20), we found 
primarily Th1 cells and T follicular helper (Tfh) CD4+GP66+ cells on 
day 8 p.i. (Figure 5C), as has been shown previously (1).
Tfh cells typically express high levels of PD-1, ICOS, and 
CXCR5, while expressing low levels of PSGL-1 (20–23). IL-10 re-
porter (Thy1.1) expression within the CD4+GP66+ cell population 
on day 8 following LCMV-Cl.13 infection generally negatively 
correlated with these Tfh cell surface markers (Figure 5C, left, 
and Supplemental Figure 7A). To further confirm that IL-10 pro-
duction was associated with non-Tfh cells, we examined IL-10 
production by PSGL1hiCXCR5lo (non-Tfh) and PSGL1loCXCR5hi 
(Tfh) cells. IL-10 production was heavily enriched in the non–Tfh 
cell population on both days 8 and 20 p.i. (Figure 5D). In contrast, 
IL-10 reporter expression positively correlated with Th1 cell mark-
ers (Figure 5C, right, and Supplemental Figure 7B). Strikingly, 
IL-10 expression was restricted to T cells with higher expression 
of the Th1 master transcriptional regulator T-bet, Th1 cell surface 
molecule Ly6C, and Th1-restricted intracellular cytolytic mole-
cule granzyme B (GZMB) (20, 22). We observed similar results in 
CD4+ T cells during acute LCMV infection (Supplemental Figure 
8, A and B). Overall, these data suggest that IL-10 is predominantly 
produced by Th1 cells, not by Tfh cells.
To examine whether IL-10 expression is associated with IFN-γ–
producing CD4+ T cells, CD4+ T cells from LCMV-Cl.13–infected 
10BiT mice were polyclonally stimulated with α-CD3 and stained 
for IFN-γ and IL-10 reporter expression. Strikingly, we found that 
IL-10 production was almost exclusively limited to IFN-γ–produc-
ing CD4+ T cells that could degranulate (CD107a+) (Figure 5E, left, 
and Supplemental Figure 7C). However, similar to effector CD8+ T 
cells, there was a negative correlation between IL-10 expression and 
Figure 6. BLIMP-1 regulates IL-10 production by 
CD4+GP66+ cells during LCMV-Cl.13 infection. (A–D) 
10BiT BLIMP-YFP mice were infected with LCMV-Arm 
or LCMV-Cl.13 and BLIMP-YFP reporter, and Thy1.1 IL-10 
reporter expression was examined within CD4+GP66+ 
tetramer+ cells on day 8 p.i. Representative profiles in A 
show YFP and Thy1.1 expression in total CD4+GP66+ cells 
in LCMV-Arm and Cl.13 infection, while B quantitates 
the Thy1.1+ cell percentage within BLIMP-YFP+ cells. 
The BLIMP-YFP MFI within YFP+-gated CD4+GP66+ Th1 
cells was compared between LCMV-Arm versus Cl.13 
infection (C) or between Thy1.1+ versus Thy1.1– cells 
during LCMV-Cl.13 infection (D). Shaded histograms 
illustrate background YFP in BLIMP-YFP transgene–
negative mice. The BLIMP-YFP MFI was normalized to 
the average MFI of cells either from the LCMV-Arm (C) 
or the Thy1.1+ cells (D). Representative and pooled data 
are from 2 (A–C) or 4 (D) independent experiments. 
(E) Ly5.1+ STg 10BiT cells were transferred into B6 mice 
subsequently infected with 2 × 106 PFU LCMV-Cl.13. On 
day 8 p.i., the Thy1.1+PSGL1hi (IL-10+ Th1), Thy1.1–PSGL1hi 
(IL10- Th1), and (Thy1.1–) PSGL1lo (Tfh) STg 10BiT cells 
were isolated by cell sorting, and Prdm1 mRNA was 
measured by quantitative RT-PCR. Data were pooled 
from 3 independent experiments. (F) Cd4-Cre+ Prdm1+/+ 
or Cd4-Cre+ Prdm1fl/fl mice were infected with 2 × 106 
PFU LCMV-Cl.13. At day 8 p.i., the CD4+GP66+ tetramer–
stained PSGL1hiLy6Chi Th1 cells were isolated by FACS, 
and Il10 mRNA was measured by quantitative RT-PCR. 
Data were compiled from 3 independent experiments. 
***P < 0.001; **P < 0.01; NS, indicates P > 0.05.
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sion correlated tightly with Thy1.1 expression, as expected (Figure 
5F, left), but while there was some evidence of elevated Il21 ex-
pression within Thy1.1– cells, this difference was not statistically 
significant (Figure 5F, right). Thus, the separation of CD8+ T cell 
helper and regulatory functions within the virus-specific CD4+ T 
cells is evident in terms of IL-2, but not IL-21, production.
IL-10 induction within Th1 cells is NFIL3 and NOTCH indepen-
dent. We next investigated the transcriptional pathways responsi-
ble for IL-10 induction within virus-specific T cells. We chose to 
focus on IL-10 regulation within virus-specific CD4+ T cells during 
chronic infection, as these cells appeared to be a more abundant 
and physiologically relevant IL-10 source than were virus-specific 
CD8+ T cells. Transcription factors such as AhR, c-MAF, NFIL3, 
and Ikaros (IKZF) induce IL-10 expression within CD4+ T cells, 
and increased expression of these factors is typically required for 
IL-10 induction. However, we failed to observe elevated expres-
TNF-α and IL-2 production within the IFN-γ+ CD4+ Th1 cell popu-
lation. Specifically, relative to IL-10– Th1 cells, IL-10+ Th1 cells had 
a lower TNF-α MFI and produced little IL-2 (Figure 5E, right, and 
Supplemental Figure 7C). Interestingly, although the few IL-10– 
producing Th1 cells that formed in acute LCMV infection exhibited 
normal TNF-α production, we found that they produced less IL-2 
(Supplemental Figure 8, C and D). Collectively, these data argue 
that the Th1 cell subset with the most impaired inflammatory func-
tion is the predominant IL-10 source.
Because IL-2 helps sustain the antiviral CD8+ T cell response 
during LCMV-Cl.13 infection (24), the inverse relationship be-
tween IL-2 and IL-10 expression suggested a separation between 
effector CD4+ T cell helper and suppressive functions. IL-21 is 
another key cytokine that helps maintain antiviral CD8+ T cell 
function and survival during LCMV-Cl.13 infection (25–27), so we 
examined its expression in virus-specific CD4+ T cells. Il10 expres-
Figure 7. TCR engagement converts CD4+GP66+ Th1 cells from acute viral infection into BLIMPhi IL-10 producers. (A) 10BiT mice were infected with 2 × 106 
PFU LCMV-Cl.13, and serum viral titers and the Thy1.1+ CD4+GP66+ and CD8+GP33+ cell frequency were correlated on day 60 p.i. for each mouse. Correlation 
coefficients (r2) are indicated, and data were pooled from 2 independent experiments. (B) 10BiT splenocytes were isolated on day 8 p.i. with either LCMV- 
Arm or LCMV-Cl.13 and transferred into infection-matched LCMV-Arm or LCMV-Cl.13 mice. Seven days later (day 15 p.i.), the Thy1.1+ cell percentage was 
measured within the activated (CD44hi) CD4+ T cells. Data were pooled from 3 independent experiments (n = 6–8 mice). (C and D) Ly5.1+ STg 10BiT BLIMP-
YFP cells were transferred into B6 mice subsequently infected with LCMV-Arm. On day 8 p.i., splenocytes were incubated with GP66–77 peptide (Peptide) or 
left untreated (No stim) for 8 hours. (C) Thy1.1 versus BLIMP-YFP expression in STg cells with or without peptide treatment. (D) Pooled data. Left graph 
shows the percentage of Thy1.1+ cells; center graph shows Thy1.1 MFI of Thy1.1+ cells; right graph shows normalized YFPhi (Th1) cell YFP MFI, with BLIMP-YFP 
MFI normalized to the “No stim” group. Data were pooled from 3 to 5 independent experiments. (E) 10BiT BLIMP-YFP mice were infected with LCMV-Arm, 
and were injected 7 days p.i. with either media or GP66–77 peptide. Twelve hours later, splenic CD4
+GP66+ tetramer–stained cells were analyzed for Thy1.1 and 
YFP expression as in C. Data were pooled from 3 independent experiments. ***P < 0.001; *P < 0.05.
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the YFPlo cell population represented Tfh cells (Supplemental 
Figure 10A). Consistent with recent findings, we also observed 
an increased proportion of YFPlo Tfh cells in chronic versus acute 
LCMV infection (Supplemental Figure 10B). In line with our ear-
lier phenotyping data, IL-10 production was largely confined to 
the YFPhi Th1 cell population, with IL-10 production elevated 
within YFPhi Th1 cells in chronic versus acute infection (Figure 
6, A and B). To examine whether BLIMP-1 expression was higher 
in Th1 cells from chronic versus acute LCMV infection, we deter-
mined the YFP MFI within the YFP+-gated (Th1) cells from mice 
infected with LCMV-Arm or Cl.13. BLIMP-YFP reporter expres-
sion was almost 2-fold higher in Th1 cells derived from LCMV- 
Cl.13 compared with those derived from Arm infection (Figure 
6C), suggesting that BLIMP-1 plays a role in IL-10 regulation. 
However, BLIMP-YFP expression analysis and quantitative RT-
PCR failed to demonstrate a statistically significant increase in 
BLIMP-1 expression in IL-10+ versus IL-10– CD4+GP66+ Th1 cells 
during Cl.13 infection (Figure 6, D and E). To examine the role of 
BLIMP-1 in IL-10 expression within virus-specific CD4+ T cells, 
Il10 transcript levels were measured in CD4+GP66+ cells sorted 
from Cd4-Cre Prdm1+/+ or Cd4-Cre Prdm1fl/fl mice. BLIMP-1 is a 
negative regulator of Tfh formation (33), so to ensure that any ob-
served differences in IL-10 expression were not due to the lower 
Th1 cell proportion within the CD4+GP66+ cell population (Sup-
plemental Figure 11A), we isolated PSGL1hiLy6Chi Th1 cells from 
both BLIMP-1–sufficient and –deficient CD4+GP66+ cells. We ob-
sion of most of these factors in STg cells during chronic versus 
acute LCMV infection, and these factors were not enriched within 
the IL-10+ STg cell population (Supplemental Figure 9A, and data 
not shown). While Nfil3 expression was elevated in STg cells dur-
ing LCMV-Cl.13, retroviral Nfil3 knockdown using an shRNA vec-
tor had no impact on STg IL-10 production (Supplemental Figure 
9, A–C). NOTCH can cause IL-10 induction in Th1 cells in coop-
eration with the transcription factor RBP-Jκ (28), however RBP-Jκ 
knockdown also had no effect on IL-10 production (Supplemental 
Figure 9, B and C). Thus, IL-10 induction within Th1 cells during 
LCMV-Cl.13 infection is NOTCH and NFIL3 independent.
Elevated BLIMP-1 expression sustains Th1 IL-10 production dur-
ing chronic viral infection. The transcription factor BLIMP-1 (en-
coded by the Prdm1 gene) was recently demonstrated to regulate 
IL-10 expression in CD8+ T cells and FOXP3+ Tregs (29, 30), so 
we next examined whether BLIMP-1 was responsible for IL-10 
induction in Th1 CD4+ T cells during chronic LCMV infection. To 
first assess BLIMP-1 expression during LCMV infection, 10BiT 
mice were crossed with a BLIMP-YFP reporter mouse (31). The 
resulting 10BiT BLIMP-YFP mice were infected with LCMV-Cl.13 
or Arm, and YFP expression was assessed within CD4+GP66+ 
cells on day 8 of infection. We observed a bimodal distribution 
of BLIMP-1 expression in both LCMV-Arm and Cl.13 infection, 
with YFPhi and YFPlo cell populations evident (Figure 6A). Based 
on surface marker expression and consistent with recent observa-
tions (32), the YFPhi cell population represented Th1 cells, while 
Figure 8. Differential ERK dependency for 
TCR-induced IL-10 versus inflammatory 
cytokine production. (A) Ly5.1+ STg 10BiT 
BLIMP-YFP cells were transferred into B6 
mice that were subsequently infected with 
LCMV-Arm. Splenocytes were isolated on 
day 8 p.i. and incubated with GP66–77 peptide 
for 8 hours along with the indicated in-
hibitors. The percentage of inhibition with 
each inhibitor relative to the appropriate 
vehicle control–treated cells is shown for 
the percentage of Thy1.1+ cells, Thy1.1 MFI 
(of Thy1.1+ cells), and BLIMP-YFP MFI (of 
BLIMP-YFPhi Th1 cells). Data were pooled 
from 2 to 7 independent experiments (7–21 
mice/group). (B and C) Ly5.1+ STg cells 
were transferred into B6 mice that were 
subsequently infected with LCMV-Arm. 
Splenocytes were isolated on day 8 p.i. and 
incubated with GP66–77 peptide for 8 hours 
as in A in the presence of either vehicle 
(DMSO) or PD98059. CD107a, IFN-γ, TNF-α, 
and IL-2 production was examined (B), and 
the percentage of inhibition of total MFI 
induction relative to DMSO control was 
calculated (C). Representative (B) or pooled 
(C) data from 3 independent experiments 
are shown (15 mice/group). ***P < 0.001; 
**P < 0.01; *P < 0.05; NS, indicates  
P > 0.05. P values in A and C measure the 
significance of treated versus control cells 
for each condition. 
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segregated with PSGL1hi Ly6Chi IFN-γhi and BLIMP-YFPhi cells 
(Figure 7C and Supplemental Figure 13A). Peptide stimulation 
did not alter the BLIMP-YFPhi cell percentage, but it did cause an 
increase in BLIMP-YFP reporter expression within the YFPhi Th1 
cell population (Figure 7D, right graph, and data not shown). IL-10 
and BLIMP-1 induction in these cultures appeared ICOS and IL-2 
independent, since antibody blockade of these factors had little 
impact on IL-10 and BLIMP-1 reporter expression (Supplemental 
Figure 13B). Importantly, restimulation-induced IL-10 expression 
was BLIMP-1 dependent, since BLIMP-1–deficient Th1 cells from 
LCMV-Arm infection were severely deficient in IL-10 expression 
upon restimulation (Supplemental Figure 14). Antigen recognition 
in vivo was also able to induce IL-10 and BLIMP-1 expression in 
LCMV-specific Th1 cells. Intravenous GP66–77 peptide administra-
tion to LCMV-Arm–infected 10BiT BLIMP-YFP mice caused a sig-
nificant increase in both IL-10 and BLIMP-1 reporter expression in 
CD4+GP66+ Th1 cells (Figure 7E). Again, the IL-10–producing cells 
were exclusively within the PSGL1hi BLIMP-1-YFPhi Th1 cell popula-
tion (Supplemental Figure 13C). Together, these data show that an-
tigen recognition in vitro and in vivo can rapidly induce IL-10 and 
BLIMP-1 expression selectively within LCMV-specific Th1 cells. 
These data therefore suggest that TCR signaling is the primary 
driver of sustained IL-10 production in virus-specific T cells during 
chronic infection and that antigen-induced, BLIMP-1–dependent 
IL-10 expression is a common feature of Th1 cells in both chronic 
and acute infection. Collectively, these results support a negative 
feedback loop model during chronic viral infection, in which per-
sisting viral antigens sustain IL-10 production in virus-specific T 
cells, thereby promoting CTL exhaustion and viral persistence.
Differential requirements for ERK signaling in IL-10 versus in-
flammatory cytokine induction. We next examined the signaling 
pathways responsible for IL-10 induction downstream of TCR en-
gagement. The in vitro antigen–induced IL-10 expression experi-
ments outlined in Figure 7, C and D, were repeated in the presence 
of a panel of inhibitors that interfere with various TCR signaling 
pathways. From this analysis, blockade of PI3 kinase signaling 
(LY294002), as well as many of the pathways downstream of PI3 
kinase (Akt [triciribine], JNK [SP600125], and NF-κB [BAY-11-
7082]), inhibited both BLIMP-1 and IL-10 induction (Figure 8A). 
Additionally, blockade of calcineurin/NFAT signaling (CsA) also 
significantly impaired BLIMP-1 and IL-10 induction (Figure 8A). 
In contrast, ERK blockade (PD98059) had little or no effect on 
IL-10 and BLIMP-1 induction.
The failure of ERK blockade to interfere with IL-10 induction 
was surprising, given previous findings that TCR-induced IL-10 ex-
pression within Th1 cells is ERK dependent (35). Furthermore, as 
ERK is thought to be important in inflammatory cytokine induction, 
this potentially implied that there are distinct signaling require-
ments for IL-10 versus inflammatory cytokine induction. To test this 
idea, we examined whether TCR-induced expression of the inflam-
matory cytokines IFN-γ, TNF-α, and IL-2, as well as degranulation 
(CD107a expression), within Th1 cells was ERK dependent. While 
ERK inhibition only slightly inhibited degranulation (CD107a ex-
pression), it moderately inhibited IFN-γ and IL-2 induction and sub-
stantially impaired TNF-α expression (Figure 8, B and C). Thus, the 
signaling requirements for TCR-induced inflammatory cyto kine 
versus antiinflammatory IL-10 induction are somewhat distinct.
served a striking loss of IL-10 expression in CD4+GP66+ Th1 cells 
deficient in BLIMP-1 expression (Figure 6F).
Importantly, although Th1 proportions were diminished in 
Cd4-Cre Prdm1fl/fl mice, the Th1 cells that did form appeared func-
tionally normal with regard to IFN-γ, TNF-α, and T-bet expres-
sion (Supplemental Figure 11, A–C), suggesting that IL-10 loss 
upon BLIMP-1 ablation was not due to abnormal Th1 differenti-
ation. Despite the IL-10 reduction in BLIMP-1–deficient T cells 
in Cd4-Cre Prdm1fl/fl mice, we did not observe augmented viral 
clearance (data not shown). However, this is likely because the 
additional defects in effector CD8+ T cell function that occur in 
the absence of BLIMP-1 (34) override any advantage of IL-10 re-
duction. These data indicate that chronic viral infection elevates 
BLIMP-1 expression within antiviral Th1 cells, which leads to 
immunoregulatory IL-10 production.
Antigen engagement induces BLIMP-1 and IL-10 in Th1 cells. A 
key environmental signal that T cells are exposed to in chronic, 
but not acute, viral infection is persistent antigen encounter. We 
thus speculated that the elevated BLIMP-1 and IL-10 expression 
in virus-specific T cells during LCMV-Cl.13 versus Arm infection 
was mediated by prolonged TCR engagement. On day 60 p.i. 
with Cl.13, we observed considerable variability between mice 
in IL-10 expression by virus-specific T cells. Consistent with the 
idea that persistent virus encounter sustains IL-10 production by 
virus-specific T cells, we observed a direct positive correlation be-
tween serum viral titers on day 60 p.i. and Thy1.1 expression of 
both CD8+GP33+ and CD4+GP66+ cells (Figure 7A). Importantly, 
both serum viral titers and CD4+GP66+ cell IL-10 production also 
positively correlated with CD8+GP33+ exhaustion (as assessed by 
PD-1 expression) (Supplemental Figure 12). To more directly test 
whether viral persistence could sustain IL-10 production, we per-
formed adoptive transfer experiments in which polyclonal effec-
tor (CD44hi) CD4+ T cells were isolated from either LCMV-Arm– 
or Cl.13-infected 10BiT mice on day 8 p.i. and transferred into 
LCMV-Arm– or Cl.13 infection–matched, congenically marked 
recipients. Seven days after transfer (day 15 p.i.), we assessed the 
IL-10–producing (Thy1.1+) cell percentage within the transferred 
effector cells. Strikingly, we found that effector cell transfer from 
either the LCMV-Arm– or the Cl.13-infected donors into Arm- 
infected recipients led to loss of IL-10 expression (Figure 7B). In 
direct contrast, effector cell transfer from either LCMV-Arm– or 
Cl.13-infected donors into Cl.13-infected recipients led to sustained 
IL-10 expression (Figure 7B). Collectively, these data demonstrate 
that virus persistence is required for sustained IL-10 production 
and argue that Th1 cells from both chronic and acute infection can 
sustain IL-10 expression when exposed to persistent virus.
To more directly test whether antigen alone was sufficient to 
induce IL-10 expression, we examined whether antigen reexposure 
could convert IL-10– STg cells from acute LCMV-Arm infection into 
IL-10 producers. B6 mice given STg cells that express the 10BiT 
and BLIMP-YFP reporters were infected with LCMV-Arm, and 
8 days p.i., the cells were incubated in vitro for 8 hours in the pres-
ence or absence of GP66–77 peptide. We observed a marked IL-10 
(Thy1.1) induction in peptide-treated cells relative to untreated 
controls, with a substantial increase in both Thy1.1+ cell percent-
age and Thy1.1 MFI (Figure 7, C and D). The IL-10–producing cells 
were restricted to the Th1 population, because IL-10 expression 
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Cl.13 infection, because IL-10 expression was only modestly in-
creased within the total CD4+ and CD8+ T cell populations in 
chronic versus acute LCMV infection (5). However, virus-specific 
T cells, which only represent a portion of the total T cell popula-
tion, were not examined directly, hence the magnitude of IL-10 
induction within T cells was likely underestimated. Indeed, DCs 
derived from Cl.13-infected mice preferentially prime IL-10–pro-
ducing CD4+ T cells in vitro (6), and T cells produce high IL-10 
levels during chronic HIV infection in humans (8, 13, 14). Impor-
tantly, we provide some of the first in vivo evidence that IL-10 
elimination from either the total T cell compartment, or to a lesser 
extent from the CD4+ T cell compartment, has an effect on both 
the antiviral T cell response and viral clearance during chronic vi-
ral infection. This conclusion is supported by another recent study 
(36), although the relative contributions of CD4+ and CD8+ T cell–
derived IL-10 were not assessed in this study. These data are in 
line with observations in other persistent nonviral infections, such 
as malaria, Leishmania, and Toxoplasma, in which effector T cell–
derived IL-10 has an impact on disease outcome (38–40). While 
our BM chimera experiments also eliminated IL-10 from Tregs, it 
is unlikely that Treg-derived IL-10 contributed to our phenotype, 
as Treg depletion during days 0–8 of LCMV-Cl.13 infection had 
little impact on the T cell response (Supplemental Figure 5).
The physiological relevance and high per-cell production lev-
els of virus-specific CD4+ T cell–derived IL-10 led us to study these 
cells in more detail. Consistent with other infectious models, IL-10 
production was observed from FOXP3– virus–specific effector Th1 
cells (38–41). Strikingly, IL-10 production was only evident within 
those Th1 cells that had diminished inflammatory function, an ob-
servation not made in previous studies. IL-10 production similarly 
segregated with the most exhausted virus-specific CD8+ T cells, 
consistent with previous findings (13, 19). Collectively, these data 
highlight that T cell exhaustion is not only associated with a loss of 
inflammatory function, but also with a gain of suppressive function. 
Importantly, IL-10+ Th1 cells specific for persistent pathogens have 
been isolated from human blood (42), indicating that these immu-
noregulatory Th1 cells are evolutionarily conserved, that they sim-
ilarly form in response to persistent infection in humans, and are 
thus likely clinically relevant to the persistence of human infections.
Surprisingly, IL-10 production was excluded from the Tfh 
compartment. The reasons for this remain unclear, as IL-10 has 
been described as a Tfh cytokine in humans (43), but it could be 
due to differences between mouse and human Tfh cells. Alterna-
tively, the signals required for Tfh IL-10 production are distinct 
from those that trigger Th1 IL-10 production, and LCMV-Cl.13 in-
fection may not generate these signals. Consistent with this idea, 
Th1 IL-10 production during LCMV-Cl.13 infection was BLIMP-1 
dependent, and BLIMP-1 is an inhibitor of Tfh differentiation that 
is typically not expressed within Tfh cells (32, 33).
Perhaps of most interest is the novel pathway responsible for 
IL-10+ Th1 cell formation during LCMV-Cl.13 infection. Many 
transcription factors, including c-MAF (44), AhR (45), NFIL3 
(46), and RBP-Jκ (28), have been linked to IL-10 expression within 
FOXP3– CD4+ T cells. However, these factors were either not up-
regulated within virus-specific CD4+ T cells during LCMV-Cl.13 
infection or were not required for IL-10 production. BLIMP-1 is a 
transcription factor recently reported to induce IL-10 expression 
Discussion
In this study, IL-10 expression kinetics were followed over the 
course of chronic LCMV-Cl.13 infection using an IL-10 reporter 
mouse. We found that virus-specific T cells, particularly virus-spe-
cific CD4+ T cells, overproduced IL-10 in chronic versus acute 
LCMV infection. Selective IL-10 loss from the T cell compartment 
had an impact on viral clearance that partially mimicked the effect 
of complete IL-10 loss, suggesting that T cell–derived IL-10 was bi-
ologically relevant. When IL-10 expression was examined within 
virus-specific CD4+ T cells, IL-10 production was restricted to the 
Th1 compartment, although it was only evident in those Th1 cells 
with the most diminished inflammatory function. IL-10 produc-
tion was similarly observed within the most exhausted virus-spe-
cific CD8+ T cells, suggesting that IL-10 production is a conserved 
feature of T cell exhaustion during chronic viral infection. IL-10 
induction within virus-specific Th1 cells appeared independent of 
many well-characterized factors linked to IL-10 induction, such as 
c-MAF, AhR, Ikaros, NFIL3, and NOTCH, with IL-10 expression 
instead dependent on elevated BLIMP-1 expression during chronic 
viral infection. Finally, TCR engagement selectively acts on the Th1 
cell population, likely in an IL-2–independent manner, to convert 
virus-specific CD4+ T cells from an acute infection into BLIMP-1hi 
IL-10 producers. Thus, persistent TCR engagement elevates 
BLIMP-1 levels in Th1 cells during chronic LCMV infection, causing 
IL-10 production and negative feedback on the T cell response.
This study is one of the first to examine IL-10 production kinet-
ics in chronic versus acute viral infection across many cell types. 
While the cell types producing IL-10 have been examined in hu-
man chronic viral infections (8–11, 13, 14), an equivalent acute viral 
infection was not available for comparison. Our data demonstrate 
that many cell types contribute to the total IL-10 pool, particularly 
at later time points of infection. However, only 3 cell types exhib-
ited elevated IL-10 expression from day 8 of infection throughout 
the course of disease: NK cells, DCs (particularly cDCs), and virus- 
specific T cells. Cell types that overproduce IL-10 from day 8 of 
infection onward are likely to play a larger role in IL-10–medi-
ated suppression, as IL-10 receptor blockade is more efficacious 
over the first 8 days of infection than at later time points (5, 6, 18). 
Thus, coupled with our finding that T cell–derived IL-10 is only 
partially responsible for IL-10–mediated immunosuppression, 
we speculate that these 3 cell types in combination are required 
for optimal IL-10–mediated immunosuppression. Together, IL-10 
production from these sources could elevate IL-10 levels above a 
threshold level required for immunosuppression during the early 
time points of chronic viral infection. Nevertheless, a recent study 
demonstrated a minimal role for NK cell–derived (and B cell– 
derived) IL-10 in immunosuppression, but supported our conclu-
sion that T cell–derived IL-10 is one of the most important IL-10 
sources during chronic viral infection (36). The role of DC-derived 
IL-10 is still unclear, as one study suggested that IL-10 ablation 
from DCs has no effect on the immune response and viral control 
(36), while another study showed a substantial effect (37).
Our study also directly demonstrates sustained and elevated 
IL-10 expression by virus-specific T cells during chronic versus 
acute LCMV infection and identifies quantitative differences in 
IL-10 production between CD4+ and CD8+ T cells. T cells were 
originally dismissed as an important IL-10 source during LCMV- 
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implications, as it implies that in certain contexts, Th1 cell inflam-
matory function could be selectively and therapeutically blocked, 
while leaving their antiinflammatory functions intact. This ap-
proach may have efficacy in Th1-driven inflammatory diseases.
It remains unclear, though, why only a portion of Th1 cells pro-
duced IL-10 during LCMV-Cl.13 infection, given that there was no 
significant difference in BLIMP-1 (or IRF4) expression between 
IL-10+ and IL-10– Th1 cells (Figure 6, D and E, and data not shown). 
This observation suggests that factors other than BLIMP-1 and IRF4 
may contribute to the formation of the IL-10+ Th1 subset. While we 
have not yet identified the molecular reason for this discrepancy, we 
have noted lower Bcl6 expression in IL-10+ versus IL-10– Th1 cells 
(Supplemental Figure 15). Since T-bet represses IL-10 production in T 
cells (52), and BCL-6 is a T-bet corepressor in Th1 cells (53), it is pos-
sible that lower BCL-6 expression in Th1 cells relieves the Il10 gene 
from T-bet–mediated repression, thereby allowing BLIMP-1–medi-
ated transcriptional activation. Indeed, BCL-6 loss promotes IL-10 
production by CD4+ T cells (54). Future work is needed to dissect the 
complex transcriptional regulation of IL-10 in antiviral CD4+ T cells 
during chronic infection, but our work identifying BLIMP-1 as an es-
sential factor provides both an important first step in this direction 
and better insight into how the host regulates the balance between 
antiviral immunity and immunopathology during a chronic infection.
Methods
Mice, infections, and plaque assays. C57BL/6NCr and CD45.1 (Ly5.1) mice 
were purchased from the National Cancer Institute. B6.129S2 Tcratm1Mom/J 
(Tcra–/–), B6.129S6 Cd4tm1Knw/J (Cd4–/–), B6.129S2 Cd8atm1Mak/J (Cd8a–/–), 
and B6.129P2 Il10tm1Cgn/J (Il10–/–) mice were purchased from The Jack-
son Laboratory. Ly5.1+ P14 (55), Prdm1fl/fl Cd4-Cre (56), BLIMP-YFP (31), 
10BiT (16), and STg (57) mice have been previously described. Mice 
were infected with 2 × 105 PFU LCMV-Arm (i.p.), 1 × 102 PFU LCMV-
clone 13 (i.v.) for acute infections, or 2 × 106 PFU LCMV-clone 13 (i.v.) for 
chronic infections. Viral titers were measured by plaque assay (31). For 
details on adoptive transfers, see Supplemental Methods.
Antibodies for surface and intracellular staining. Lymphocyte iso-
lation, surface staining, tetramer staining, and intracellular staining 
were performed as described previously (20, 31). See Supplemental 
Methods for more details.
BM chimeras. BM chimeras were generated as previously described 
(31). Thy1.1 mice were used as recipients, and injections with the 
Thy1.1-depleting antibody 19E12 were used to ensure depletion of any 
surviving host T cells.
Retroviral knockdown. An LMP retroviral vector (Open Biosys-
tems) with the puromycin resistance gene removed (32) was used 
for retroviral transductions and was a gift of Shane Crotty (La Jolla 
Institute for Allergy and Immunology, La Jolla, California, USA.). 
The sequences for knockdown were: NFIL3, CCCGCACAAGCTTC-
GGATTAAA, and RBP-Jκ, AAAGGAGAGGAGTTCACAGTTA from 
Open Biosystems, using shRNAmir flanking sequences. See Supple-
mental Methods for additional details.
Cell isolation and stimulation. Cells were sorted using a FACSAria 
sorter (BD Biosciences). In some experiments, transferred Ly5.1+ STg 
cells were enriched using biotinylated Ly5.1 antibody and streptavidin 
microbeads (Miltenyi Biotec) prior to sorting. In experiments involv-
ing stimulation, cells were either stimulated in tissue culture plates 
precoated with 1 μg/ml α-CD3 (clone 17A2) or with 20 ng/ml PMA and 
both in virus-specific CD8+ T cells during influenza infection (30) 
and in Tregs (29), however it has not been implicated in IL-10 ex-
pression in effector CD4+ T cells. Thus, to our knowledge, our data 
represent the first demonstration that BLIMP-1 expression is ele-
vated in Th1 cells during chronic viral infection and also the first 
report that BLIMP-1 regulates IL-10 in effector CD4+ T cells. Cou-
pled with observations that BLIMP-1 negatively regulates CD8+ 
T cell function during LCMV-Cl.13 infection by inhibitory receptor 
induction (34), these data argue that BLIMP-1 plays diverse roles 
in inhibiting the T cell response during chronic viral infection.
Finally, we found that TCR engagement induced BLIMP-1 and 
IL-10 expression in Th1 cells from an acute infection, which impli-
cates antigen as a key signal that sustains IL-10 production during 
LCMV-Cl.13 infection. In other systems, BLIMP-1 upregulation in 
T cells depends on IL-2 and STAT3-dependent cytokines (30, 47, 
48). We currently have little evidence for a role of STAT3-depen-
dent cytokines in IL-10 induction during LCMV-Cl.13 infection, as 
CD4+GP66+ cells isolated from Gzmb-Cre Stat3fl/fl mice, in which 
STAT3 is partially floxed in activated CD4+ T cells, have no defect 
in IL-10 expression during LCMV-Cl.13 infection (data not shown). 
IL-2 was recently linked to both BLIMP-1 and IL-10 induction 
within CD8+ T cells (30), but chronic infection is associated with di-
minished IL-2 production by virus-specific T cells and lower serum 
IL-2 levels (49). Furthermore, IL-2 administration promotes, rather 
than inhibits, viral clearance (50), meaning IL-2 is unlikely to me-
diate IL-10 induction. Consistent with this idea, IL-2 blockade had 
little impact on BLIMP-1 and IL-10 induction in vitro (Supplemen-
tal Figure 13B). Furthermore, in vivo IL-2 blockade during chronic 
LCMV infection did not affect BLIMP-1 or IL-10 expression in pre-
liminary experiments (data not shown). Instead, IRF4 is a likely 
downstream candidate involved in TCR-induced BLIMP-1 and 
IL-10 expression, because IRF4 is a known activator of BLIMP-1 ex-
pression and can be upregulated by TCR stimulation (29, 48, 51). In 
support of this model, IRF4 expression is elevated in Th1 cells dur-
ing chronic versus acute LCMV infection in vivo and was induced 
by in vitro peptide stimulation in parallel with BLIMP-1 and IL-10 
(data not shown). Furthermore, inhibitors that prevented BLIMP-1 
and IL-10 induction also interfered with IRF4 induction in Th1 cells 
upon in vitro antigen engagement (data not shown). Indeed, 2 of the 
pathways required for IL-10 production (NF-κB and NFAT) (Figure 
8A) induce IRF4 expression downstream of TCR engagement (51). 
Therefore, we postulate that sustained TCR engagement triggers 
BLIMP-1 upregulation and IL-10 expression via IRF4 induction. 
This pathway may represent an alternative way to engage the IRF4/
BLIMP-1/IL-10 axis in effector (and possibly regulatory) T cells.
While TCR engagement induces expression of many cytokines, 
our data additionally reveal that the signaling requirements for 
TCR-induced antiinflammatory IL-10 expression differ from those 
for inflammatory cytokine production. Our data indicate that IL-10 
induction is ERK independent, a surprising finding, given that 
TCR-dependent IL-10 induction in in vitro–generated Th1 cells is 
ERK dependent (35). The reason for this discrepancy may relate to 
the c-MAF dependency of IL-10 production; while c-MAF did not 
appear to be involved in IL-10 expression by Th1 cells during Cl.13 
infection, c-MAF was implicated in IL-10 production in the study 
by Saraiva et al. (35). The differential signaling requirements for 
IL-10 versus inflammatory cytokine production may have clinical 
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1 μM Ca2+ ionophore (ionomycin) for the indicated times (Figure 1, 
Figure 3, Figure 5, Supplemental Figure 8, and Supplemental Figure 
14). For IL-10 ELISAs, the CBA Mouse IL-10 Flex Set was used (BD 
Biosciences). For more details, see Supplemental Methods.
RNA isolation and quantitative RT-PCR. RNA was isolated from 
cells using an RNeasy Kit (QIAGEN), and cDNA was synthesized with 
Superscript II (Invitrogen). Real-time PCR was performed using the 
Brilliant III Ultra-Fast QPCR Master Mix (Agilent Technologies) on a 
Stratagene MX3000P real-time PCR machine (Agilent Technologies). 
Expression was normalized using the housekeeping gene Rpl9. The 
primers used for amplification are listed in Supplemental Table 1. AhR 
expression was measured using the Mm00478930-ml primer-probe 
mixture from Applied Biosystems.
Statistics. All error bars represent SEM. A P value of less than 
0.05 was considered statistically significant. For more details, see 
Supplemental Methods.
Study approval. All animal experiments were performed with 
the approval of the IACUC of Yale University (New Haven, Con-
necticut, USA).
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